AstraZeneca vaccine booster works against Omicron

Advertise with us

Advertise with us

QatarDay

Health & Wellbeing

Study

AstraZeneca vaccine booster works against Omicron, Oxford lab study finds

A three-dose course of AstraZeneca's (AZN.L) COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study. Findings from t..
Higher risk of heart complications from COVID-19 than vaccines -study

COVID-19 infections are more likely to trigger rare cardiovascular complications such as heart inflammation and irregular heartbeat than vaccines, a British study showed on Tuesday, after scientists parsed data of about 38 million vaccinated people. ..
U.S. study suggests vaccines may be ineffective against Omicron without booster

All three U.S.-authorized COVID-19 vaccines appear to be significantly less protective against the newly-detected Omicron variant of the coronavirus in laboratory testing, but a booster dose likely restores most of the protection, according to ..
Obesity costing Saudi Arabia $19 billion per year: Study

Obesity is costing Saudi Arabia $19 billion per year, and that figure could skyrocket by 2060 if the issue is not addressed, according to a new study. Published by BMJ (British Medical Journal) Global Health, the study surveyed eight countries, an..
7 Part Time Jobs to Earn Money When You Study in Qatar

Studying at universities in Qatar can burn a considerably large hole in the pockets of any parent. Especially if you come from any of the myriad expatriate communities that call this tiny Arabian state as home. Indubitably, living costs in Qatar are ..
Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study

A booster dose of the COVID-19 vaccine developed by Pfizer Inc (PFE.N) and German partner BioNTech SE (22UAy.DE) was 95.6% effective against the coronavirus when compared to a vaccinated group that did not get the third shot, data..
Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows

The effectiveness of the Pfizer Inc (PFE.N)/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when ..
Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study

An antiviral pill developed by U.S. drugmaker Merck & Co (MRK.N) could half the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, with experts hailing it as a potential breakthrough in how the..
Pfizer begins study of oral drug for prevention of COVID-19

Pfizer Inc (PFE.N) said on Monday it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The drugmaker and its rivals, includi..

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories